Dr. Len WalT, M.D., MBA

Dr. Len WalT, M.D., MBA

Chief Medical Officer

Dr. Len Walt is the Chief Medical Officer at CannTrust. Dr. Walt comes to CannTrust with extensive senior leadership experience in the pharmaceutical and biotechnology industries in Canada, USA and abroad. He oversees the global medical function dedicated to strengthening CannTrust’s clinical research strategy, medical education programs, product innovation and support the expansion of CannTrust’s global medical businesses and partnerships. 

Most recently Dr. Walt held the position of Vice President and Head of Medical Affairs at Sobi Inc., where he led their North American medical and scientific operations. Previously, Dr. Walt held the position of Medical Director at Biogen Canada where he built best-in-class medical teams and developed strong relationships with key clinical investigators in Canada.

Prior to this he held senior executive positions with several major multinational pharmaceutical and biotechnology companies, both in Canada and abroad. Dr. Walt was Vice-President, Research and Development, of Glycodesign Inc, a Canadian biotechnology company. He was the Medical Director of Hoffman La Roche Canada, and Medical Advisor of Glaxo Wellcome Canada. He was also Medical Director of Hoechst South Africa. Prior to his industry experience he practiced as a medical doctor in a family medicine practice.

CANNTRUST

Since 2013, CannTrust has been delivering standardized products that enable physicians to provide accurate dosage to patients, similar to pharmaceuticals, all while rapidly building capacity and capability to expand into new categories: the adult use market, over-the-counter, natural healthcare products, pet care, and beauty.

SUBSCRIBE TO INVESTOR NEWSLETTER

Subscribe Now

FOLLOW US

© CannTrust 2019

Terms & Conditions

Pin It on Pinterest